Latest From Biotech Now

BIO One-on-One Partnering Opens for BIO International Convention

Partnering

The 2013 BIO International Convention and BIO Business Forum is kicking in to full gear! And today is a big day! The BIO One-on-One Partnering System™ for the event has officially launched! This means that login credentials are being sent to registered participants, who can access the site to set up their profiles and send and accept meeting requests. We had a stellar year last year, where records were legitimately broken. So here’s to breaking new Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Gene Patents: Common Sense from Down Under

Credit - australiaphotos.co.uk

Oh, crikey! The U.S. Supreme Court is currently reviewing briefs to consider whether preparations of DNA molecules are patentable. Possibly unnoticed to the Justices is a recent decision from the Federal Court of Australia confirming the patentability of ‘isolated’ DNA. The Supreme Court may not take any notice of this Australian case, but those following so-called gene patents can learn a lot from the no-nonsense approach of Aussie patent law. The Australian case focuses its Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Show Me the Money: Reimbursement in an ACA World

BIO CEO 2013

A panel at the BIO CEO & Investor Conference focused on reimbursement discussed value from a variety of perspectives and agreed that the landscape is shifting dramatically. The reimbursement roundtable featured payors, providers, and other stakeholders discussing Affordable Care Act (ACA) implementation and the wider reimbursement landscape. With many key provisions of the ACA slated to take effect in 2013 and beyond, the industry is facing sweeping changes to the managed care and reimbursement road map. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

More Farmers Around the World Plant Biotech Crops

Farmer

ISAAA (International Service for the Acquisition of Agri-Biotech Applications) released their annual report last week on the Global Status of Commercialized Biotech/GM Crops: 2012, showing a record 17.3 million farmers in 28 countries are growing biotech crops on 420 million acres. That marks a pretty stunning 100-fold increase since biotech crops were first commercialized in 1996. Even more impressive is the role developing countries are playing in the growth of biotech crops. Business-Standard.com reported on Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Orphan Drugs: Making Rare Diseases Rarer

Panel

A panel at the BIO CEO & Investor Conference provided an analysis of the thriving orphan drug market opportunity featuring industry, clinical and regulatory experts specializing in rare diseases. The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering innovation for rare diseases. With a record 460 medicines in late-stage clinical trials, biopharmaceutical companies have embraced rare disease medicine and are rapidly developing the pipeline with hopes of achieving the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,